Lack of meaningful genotype-phenotype association in SCN1A-related infantile-onset epileptic encephalopathies
- Author:
Siti Aishah Abdul Wahab
;
Yusnita Yakob
;
Teik-Beng Khoo
;
Sangita Dharshini Terumalay
;
Vigneswari Ganesan
;
Chee-Ming The
;
Nor Azni bin Yahaya
;
Hock-Sin Heng
;
Manonmani Vaithialingam
;
Sau-Wei Wong
- Publication Type:Journal Article
- Keywords:
SCN1A mutations;
epileptic encephalopathies;
genotype-phenotyp
- From:Neurology Asia
2017;22(2):99-111
- CountryMalaysia
- Language:English
-
Abstract:
Background & Objective: SCN1A gene which encodes for sodium channel alpha 1 subunit has been
found to be the most common mutated gene in patients with epilepsy. This study aims to characterize the
SCN1A mutations as well as to describe genotype and phenotype association in children with SCN1Arelated
infantile-onset epileptic encephalopathies in Malaysia. Methods: Children with infantile-onset
epileptic encephalopathy mostly suspected to have Dravet syndrome who had mutational analysis for
SCN1A gene from hospitals all over Malaysia were included in the study. Their epilepsy syndrome
diagnosis was classified into severe myoclonic epilepsy in infancy and its variants. Polymerase chain
reaction and bidirectional sequencing were used to identify SCN1A mutations. Results: A total of 38
children with heterozygous mutations were analysed, 22 (57.9%) of which were novel mutations.
Truncated mutations were the most common mutation type (19, 50%). Other mutation types were
missense mutations (14, 36.8%), splice site mutations (4, 10.5%) and in-frame deletion (1, 2.6%). The
mean age of seizure onset was 4.7 months. Seizure following vaccination was observed in 26.3% of
the children. All of them had drug resistant epilepsy. There was no significant association between
the type of mutation with the syndromic diagnosis, age of seizure onset, tendency of the seizures to
cluster or having status epilepticus, mean age when developmental delay was observed and response
to various antiepileptic drugs.
Conclusion: This study expands the spectrum of SCN1A mutations and proves the importance of
SCN1A gene testing in diagnosing infantile-onset epileptic encephalopathies patients. Although, our
study does not support any clinically meaningful genotype-phenotype association for SCN1A-related
infantile-onset epileptic encephalopathies, the clinical characteristics of our cohort are similar to those
that have been described in previous studies.
- Full text:P020170710322153855491.pdf
